USE OF HSP90 INHIBITORS TO OVERCOME TRASTUZUMAB RESISITANCE IN THE MINOR VARIANT OF HER2 P95HER2 IN BREAST CANCER

dc.contributor.advisorBeyer, Rachel
dc.contributor.authorAlraddadi, Mohammed
dc.contributor.departmentDepartment of Biologyen_US
dc.contributor.programBiomedical Scienceen_US
dc.date.accessioned2018-12-14T17:00:12Z
dc.date.available2018-12-14T17:00:12Z
dc.date.issued2018-11-30
dc.genreMock Grant Proposalsen_US
dc.identifierdoi:10.13016/M2P26Q752
dc.identifier.urihttp://hdl.handle.net/11603/12264
dc.language.isoen_USen_US
dc.relation.isAvailableAtHood College
dc.titleUSE OF HSP90 INHIBITORS TO OVERCOME TRASTUZUMAB RESISITANCE IN THE MINOR VARIANT OF HER2 P95HER2 IN BREAST CANCERen_US
dc.typeTexten_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
BMS 571 Final Draft_RKB.pdf
Size:
1.11 MB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.01 KB
Format:
Item-specific license agreed upon to submission
Description: